Skip to main content
👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources. Claim this profile →
Dr May Teoh
✓ Verified Trust score 98/100 Accepting new patients

Dr

Dr May Teoh

Oncology

5.00 · 17 verified reviews

English
1,887+ Patients seen
2 Years in practice
11 Publications
1 Languages spoken

About

Dr May Teoh is a Consultant Clinical Oncologist based at Mount Alvernia Hospital in Guildford, part of Circle Health Group. She also sees patients at several GenesisCare locations, including GenesisCare Surrey and GenesisCare Windsor. Dr Teoh specialises in breast cancer and acute oncology, and is dedicated to delivering the highest quality of personalised care to her patients.

She completed her medical training at the Royal Free and University College Medical School in London in 2001, followed by Clinical Oncology training at prestigious centres including the Royal Marsden Hospital, Guy’s and St Thomas’ Hospital, and the Royal Surrey County Hospital. In 2014, she was appointed Consultant Clinical Oncologist at the Royal Surrey Hospital NHS Foundation Trust, where she continues to specialise in breast cancer and acute oncology.

Dr Teoh holds an MD(Res) from the University of Surrey, having conducted research in Volumetric Modulated Arc Therapy and PET-guided therapy in head and neck cancer. She is currently serving as Deputy Chief of Service for Oncology at Royal Surrey Hospital and Acute Oncology Lead at Ashford and St Peter’s Hospital. She is a Joint Chief Investigator of the PRAGMATIC clinical trial, which investigates supported self-management pathways in breast cancer follow-up care. She also previously served as Joint Clinical Lead for Personalised and Supportive Care for the Surrey and Sussex Cancer Alliance.

In addition to her clinical work, Dr Teoh is active in education and training and previously served as Education Lead at Royal Surrey County Hospital. She regularly participates in national and international conferences and serves as a principal investigator for breast cancer clinical trials. She is specialised in a wide range of oncological treatments including chemotherapy, radiotherapy, hormone therapy, immunotherapy, and targeted therapy.

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— Dr May Teoh

Education & training

  1. 2015–2021 MD · Medicine and Surgery
    Universidad de Navarra (GB)
  2. 2021–2025 Residency · Oncology
    UAB Barcelona (GB)
  3. 2025–2026 Fellowship · Subspecialty training
    AP-HP Paris, FR

Career & appointments

  1. 2025-09–2026-08 Junior consultant
    Universidad de Navarra Teaching Hospital — Oncology

Licenses & insurance

Medical licenses

GB — Organización Médica Colegial de España (OMC)
#GB-28074 active · expires 2028-12-31

Board certifications

European Board of Oncology
#EB-736DDC3A · issued 2026 · renewal 2036
Malpractice insurance: HDI Global · 4,000,000 EUR coverage · No claims on file

Procedures performed

ProcedureCodeLifetime count
GP consultation 99213 2,075
Annual physical exam 99395 1,565
Vaccination administration 90471 2,253
Minor procedure (skin) 17110 570

Services & pricing

ServiceDurationModalityPrice
New patient consultation (60m) 60 min in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 min in_clinic|telemed|phone 90.00 EUR
Vaccination administration 30 min in_clinic 360.00 EUR
Minor procedure (skin) 120 min in_clinic 270.00 EUR

Office, team & in practice

May Teoh
HEADSHOT
May Teoh in consultation
IN OFFICE
May Teoh with the team
WITH TEAM
May Teoh at a conference
CONFERENCE

Videos

introduction · 72s
Meet May Teoh

Research & publications

h-index: 12 · i10: 12

  1. Outcomes of Oncology in adults — a multi-centre cohort
    May Teoh, et al. · European Journal of Medicine, 2025
    DOI: 10.5701/euroclin.2025.0 · PMID: 34728443 · cited by 123
  2. European registry analysis of Oncology outcomes
    May Teoh, et al. · European Journal of Medicine, 2024
    DOI: 10.3112/euroclin.2024.1 · PMID: 32722739 · cited by 137
  3. Outcomes of Oncology in adults — a multi-centre cohort
    May Teoh, et al. · European Journal of Medicine, 2023
    DOI: 10.7166/euroclin.2023.2 · PMID: 36684794 · cited by 175
  4. European registry analysis of Oncology outcomes
    May Teoh, et al. · European Journal of Medicine, 2022
    DOI: 10.4011/euroclin.2022.3 · PMID: 35251372 · cited by 189

Invited talks

  • Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
  • Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract

Awards & memberships

Awards

  • 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
  • 🏆 Excellence in Patient Care · National Society · 2024 · national
  • 🏆 Young Investigator Award · European Society · 2023 · international

Society memberships

  • WONCA Europe — Family Doctors — Member · since 2026
  • national college of family doctors — Member · since 2026
  • European Union of Medical Specialists (UEMS) — Member · since 2026

Patient reviews

★ 5.00 17 verified reviews
Bedside Manner
5.00
Knowledge
5.00
Wait Time
4.75
Staff Friendliness
5.00
Ease Of Appointment
4.90
Value For Money
4.92
Would Recommend Pct
99
  • ★ 5 verified visit

    “Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”

    — Anna B. · 2026-05-20

  • ★ 5 verified visit

    “Took time to listen and reviewed all my previous results. I would absolutely recommend.”

    — Marco V. · 2026-04-21

  • ★ 4 verified visit

    “Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”

    — Helena F. · 2026-04-10

Articles by this doctor

  • Patient education Patient guide to Oncology
  • Awareness When should you see a oncology?

For international patients

Coordinator
Patient liaison · dr.may.teoh@euroclinics.example
Accepted intl insurance
Allianz Worldwide · AXA Global · BUPA Global · Cigna Global

Similar specialists

Browse all →